Tag: CBT > Medical Cannabis Research Cannabinoids: Page 6

Industry Headlines

UCLA's Cannabis Research Initiative Awarded First Grant for Clinical Study from NIH

The National Institutes of Health has awarded a $3.5 million grant to UCLA's Cannabis Research Initiative to examine the pain-relieving effects of cannabis and its constituents in a clinical study. The study will also look at experiential differences associated with biological sex.

November 21, 2019

Kentucky

New Study Suggests Full-Spectrum Hemp CBD May Reduce or Eliminate Opioid Usage and Improve Quality of Life Measures

Ecofibre's Ananda Health Division reports promising results in largest-of-its-kind single-arm cohort study on opioid reduction and pain improvement using Kentucky-sourced hemp CBD.

November 14, 2019

International

Hope for Veterans Fighting PTSD: A New Study on Cannabis from Canada

Many suffering from post-traumatic stress disorder have sought out cannabis therapy as a safe and effective treatment for debilitating symptoms. A new analytical review of Canadian patient data suggests there is some evidence for its efficacy.

November 11, 2019

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019

International

UK Research Institution Studying CBD for Symptoms of Psychosis in Parkinson's Patients

King's College London receives charitable donation from Parkinson's UK to begin a first-of-its-kind clinical trial to study the effects of CBD on psychosis symptoms in patients with early-stage Parkinson's disease.

October 21, 2019

Hemp Research

CBD for Arthritic Dogs: University 'Clinical' Trial

University of Pennsylvania set to partner with Denver-based Dixie Brands, Inc. in first-ever double-blind placebo CBD trial for dogs suffering from osteoarthritis.

October 11, 2019

International

Cannabis Goes Down Under for First-Ever Human Trial on Dementia

The Institute for Health Research at University of Notre Dame in Western Australia recently announced the start of a ground-breaking clinical trial to discover how cannabis can alleviate symptoms associated with dementia.

October 7, 2019

Finance

Australia’s Government Invests $3 Million in Medical Cannabis Research

The federal government will provide the funds to investigate how cannabis can help cancer patients.

October 7, 2019

Interviews & Opinion

Responding to the Recent U.S. Surgeon General Cannabis Advisory

The language—and the evidence—we use to describe cannabis is important to the industry's success.

October 2, 2019

International

Dr. Mechoulam Does It Again

In an exciting mainstream media report, NBC news highlighted a groundbreaking new development from the lab of Dr. Raphael Mechoulam, the godfather of cannabis chemistry: cannabinoid acids.

September 27, 2019

Hemp Research

The Arthritis Foundation Releases Fundamental Guidelines for CBD Therapy

The Arthritis Foundation, in collaboration with leading specialists, offers progressive guidance for better consumer outcomes with its practical educational resource on adult-use cannabis therapy for arthritic symptom management.

September 25, 2019

Finance

Green Thumb Industries (GTI) Closes Transaction to Acquire Highly Coveted Vertically Integrated New York License

New York’s medical marijuana market has more than 105,000 registered patients as of August 20, almost doubling since January 2018.

August 26, 2019